ORAMED PHARMACEUTICALS INC. Quarterly Common Stock, Shares Authorized from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Oramed Pharmaceuticals Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2011 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 60M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 60M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 60M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 60M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 60M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 60M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 60M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 60M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 60M 0 0% Dec 31, 2022 10-K 2024-03-06
Q3 2022 60M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 60M 0 0% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 60M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 60M 0 0% Dec 31, 2021 10-K 2023-03-06
Q3 2021 60M 0 0% Aug 31, 2021 10-QT 2022-03-30
Q2 2021 60M +30M +100% May 31, 2021 10-Q 2021-07-14
Q1 2021 60M +30M +100% Feb 28, 2021 10-Q 2021-04-13
Q4 2020 60M +30M +100% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 60M 0 0% Aug 31, 2020 10-K 2021-11-24
Q2 2020 30M 0 0% May 31, 2020 10-Q 2020-07-07
Q1 2020 30M 0 0% Feb 29, 2020 10-Q 2020-04-06
Q4 2019 30M 0 0% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 60M +30M +100% Aug 31, 2019 10-K 2020-11-24
Q2 2019 30M 0 0% May 31, 2019 10-Q 2019-07-10
Q1 2019 30M 0 0% Feb 28, 2019 10-Q 2019-04-10
Q4 2018 30M 0 0% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 30M 0 0% Aug 31, 2018 10-K 2019-11-27
Q2 2018 30M 0 0% May 31, 2018 10-Q 2018-07-12
Q1 2018 30M 0 0% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 30M 0 0% Nov 30, 2017 10-Q 2018-01-11
Q3 2017 30M 0 0% Aug 31, 2017 10-K 2018-11-28
Q2 2017 30M 0 0% May 31, 2017 10-Q 2017-07-06
Q1 2017 30M 0 0% Feb 28, 2017 10-Q 2017-04-05
Q4 2016 30M 0 0% Nov 30, 2016 10-Q 2017-01-11
Q3 2016 30M 0 0% Aug 31, 2016 10-K 2017-11-29
Q2 2016 30M 0 0% May 31, 2016 10-Q 2016-07-06
Q1 2016 30M 0 0% Feb 29, 2016 10-Q 2016-04-06
Q4 2015 30M 0 0% Nov 30, 2015 10-Q 2016-01-13
Q3 2015 30M 0 0% Aug 31, 2015 10-K 2016-11-25
Q2 2015 30M 0 0% May 31, 2015 10-Q 2015-07-01
Q1 2015 30M +13.3M +80% Feb 28, 2015 10-Q 2015-04-03
Q4 2014 30M +13.3M +80% Nov 30, 2014 10-Q 2015-01-08
Q3 2014 30M +13.3M +80% Aug 31, 2014 10-K 2015-11-25
Q2 2014 30M +13.3M +80% Jul 23, 2014 10-K 2014-11-14
Q1 2014 16.7M 0 0% Feb 28, 2014 10-Q 2014-04-10
Q4 2013 16.7M -183M -91.7% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 16.7M 0 0% Aug 31, 2013 10-K 2014-11-14
Q2 2013 16.7M -183M -91.7% May 31, 2013 10-Q 2013-07-17
Q1 2013 16.7M -183M -91.7% Feb 28, 2013 10-Q 2013-04-11
Q4 2012 200M 0 0% Jan 22, 2013 10-K 2014-11-14
Q3 2012 16.7M -183M -91.7% Aug 31, 2012 10-K 2013-11-27
Q2 2012 200M May 31, 2012 10-Q 2012-07-12
Q1 2012 200M Feb 29, 2012 10-Q 2012-04-04
Q4 2011 200M Nov 30, 2011 10-Q 2012-01-12
Q3 2011 200M Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.